KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $7.7 million.

  • Astrana Health's Share-based Compensation rose 2419.35% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year increase of 5154.92%. This contributed to the annual value of $34.5 million for FY2024, which is 5669.69% up from last year.
  • As of Q3 2025, Astrana Health's Share-based Compensation stood at $7.7 million, which was up 2419.35% from $11.7 million recorded in Q2 2025.
  • Astrana Health's 5-year Share-based Compensation high stood at $15.2 million for Q4 2024, and its period low was $1.3 million during Q1 2021.
  • For the 5-year period, Astrana Health's Share-based Compensation averaged around $5.6 million, with its median value being $5.6 million (2022).
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 19369.7% in 2021, then soared by 747.45% in 2023.
  • Astrana Health's Share-based Compensation (Quarter) stood at $2.4 million in 2021, then soared by 132.11% to $5.6 million in 2022, then surged by 54.27% to $8.7 million in 2023, then skyrocketed by 75.6% to $15.2 million in 2024, then tumbled by 49.46% to $7.7 million in 2025.
  • Its Share-based Compensation was $7.7 million in Q3 2025, compared to $11.7 million in Q2 2025 and $7.8 million in Q1 2025.